NCT06287775 2026-03-12Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung CancerNational Cancer Institute (NCI)Phase 1/2 Recruiting45 enrolled